FDA Approved: ONDANSETRON — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ondansetron from Rising Pharma Holdings, Inc., under the existing ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Postoperative Nausea and Vomiting

Drugs mentioned

• Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON)